JENNIFER LIN: Open Payments
NPI 1467404277 · APOPKA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,084 in 53 payments from 23 companies in 2025. Trend: 2023 $1,525 · 2024 $699 · 2025 $2,084
Food & beverage: $2,084
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $387 |
| Sequel Med Tech, LLC | 3 | $192 |
| RECORDATI_RARE_DISEASES_INC. | 5 | $179 |
| Lilly USA, LLC | 3 | $163 |
| VIVUS LLC | 7 | $161 |
| Novo Nordisk Inc | 2 | $138 |
| Amgen Inc. | 2 | $133 |
| Astellas Pharma US Inc | 1 | $130 |
| KYOWA KIRIN, INC. | 1 | $119 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $95 |
Products named: QULIPTA, TWIIST, ISTURISA, PANCREAZE, Ozempic, Veozah, ZEPBOUND, CREON.
Industry payments across FL — which companies pay providers there.
